Mass Spectrometry: Opportunities in the Life Science Market

BioInformatics, LLC

Mass spectrometry (MS) is an analytical technique that is used to identify unknown compounds, quantify known compounds, and elucidate the structure and chemical properties of molecules. Originally used by pharmaceutical companies to conduct drug research, MS has a host of potential applications—ranging from detecting chemical agents for biodefense to facilitating the quantification of complex proteins.

Bioinformatics Business: Technical Status and Market Prospects

Business Communications Company Inc

Bioinformatics is a set of enabling technologies responsible for the annotation, storage, analysis and search/retrieval of nucleic acid sequence, protein sequence and structural information. This includes integration of the information on the sequences and structures of nucleic acids and proteins into databases such as EMBL, as well as methods to access, search, model and analyze this information.

U.S. Life Science Mass Spectrometry Markets

Frost & Sullivan

This Frost & Sullivan research service entitled U.S. Life Science Mass Spectrometry Market provides a market forecast for mass spectrometers, taking into account two or three items that are included in the study. In this research, Frost & Sullivan's expert analysts thoroughly examine the mass spectrometry market, composed of the following: single quadrupole, triple quadrupole, ion trap, MALDI, and high resolution mass spectrometry. This analysis is available through our Drug Discovery Technologies Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Advances in Bioinformatics and Clinical Informatics

Frost & Sullivan

Genome sequencing and numerous studies related to proteins have left researchers grappling with massive quantities of data that is rapidly approaching a petabyte (over quadrillion bytes). Bioinformatics is fast emerging as the one-stop solution to store, manage, retrieve, organize, compare, and integrate the data all in a single computer. By using databases, tools, algorithms, and interfaces, bioinformatics is proving to be both a cost and time saving solution for handling complex biological information.

Bioinformatics

Global Industry Analysts

These Strategic Business Reports are typically 200-500+ pages long and aspire to deliver the most extensive coverage possible at the global level with detailed analytics at the product segment level. These reports mostly address key industry issues, trends, drivers, limiters, and facts. A thorough product segment analysis is often supported with end user industry analysis.

Systems Biology at the Crossroads: Insights from the Life Science Insights and Bio-IT World-Sponsored Systems Biology Modeling Roundtable

IDC

This Health Industry Insights Flash covers the perspective framing the Life Science Insights and Bio-IT World sponsored systems biology modeling roundtable. In bringing together industry, vendors, and academic thought leaders, this roundtable forum provided an opportunity to discuss the needs and expectations of the key stakeholders with a goal of advancing the dialogue toward knowledge-based drug development.

Outsourcing in Drug Discovery, 2nd Edition

Kalorama Information

In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term "2nd Edition" hardly seems appropriate. This new study involved completely re-examining the market from the ground up. This new report is designed to make readers aware of the enormous changes that are taking place in the drug discovery outsourcing market, and the forces that are shaping the sector. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 30 suppliers, representative of those active in this market.

Bioinformatics Market Update (2006)

RNCOS

The research report ‘Bioinformatics Market Update (2006)' provides an updated and detailed overview of the Bioinformatics industry worldwide. It examines the emerging trends and provides exclusive forecasts, the snapshots of different players in the industry and the market revenue of different product categories. The report gives an overview of the Bioinformatics market segments and explains how they are poised for future growth and the development of new technologies.

World Bio-Informatics Market (2005-2010)

RNCOS

In the recent years, the continuously changing market of bioinformatics applications enjoys a wide acceptance owing to declining new drugs’ manufacturing, non existence of potential drugs and expiry of patents. In 2004-05, this market with a US $1.4 billion has been competing with unusual and innovative tools facilitating critical R&D for the bioinformatics companies.

Bioinformatics Markets

Trimark Publications

The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. TriMark Publications believes that many of the segments of bioinformatics described in this report offer an unusual opportunity for accelerated expansion within the coming years. This study is arranged to provide an overview of bioinformatics market segments and offer evidence that these segments are poised for significant future growth.